Orthofix Medical Inc. $OFIX Shares Sold by AWM Investment Company Inc.

Key Points

• AWM Investment Company Inc. significantly reduced its stake in Orthofix Medical, selling 293,536 shares and now holding only 66,611 shares, which represents an 81.5% decrease in ownership.
• Juniper Investment Company LLC increased its stake in Orthofix Medical by 123.5%, acquiring over 1 million additional shares, highlighting a shift in investor sentiment.
• Orthofix Medical missed analysts' earnings expectations for the latest quarter, reporting a loss of ($0.36) earnings per share, while revenue was slightly above estimates at $203.12 million.

AWM Investment Company Inc. trimmed its holdings in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 81.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,611 shares of the medical device company's stock after selling 293,536 shares during the quarter. AWM Investment Company Inc. owned about 0.17% of Orthofix Medical worth $1,086,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. PDT Partners LLC purchased a new position in Orthofix Medical in the 1st quarter worth approximately $548,000. Cubist Systematic Strategies LLC raised its position in shares of Orthofix Medical by 161.9% during the 1st quarter. Cubist Systematic Strategies LLC now owns 78,220 shares of the medical device company's stock valued at $1,276,000 after buying an additional 48,353 shares during the period. Trexquant Investment LP increased its holdings in Orthofix Medical by 8.7% in the 1st quarter. Trexquant Investment LP now owns 60,536 shares of the medical device company's stock valued at $987,000 after purchasing an additional 4,856 shares during the last quarter. Gamco Investors INC. ET AL boosted its holdings in Orthofix Medical by 1.0% during the 1st quarter. Gamco Investors INC. ET AL now owns 157,100 shares of the medical device company's stock valued at $2,562,000 after acquiring an additional 1,500 shares during the period. Finally, Keeley Teton Advisors LLC boosted its holdings in Orthofix Medical by 36.4% during the 1st quarter. Keeley Teton Advisors LLC now owns 83,657 shares of the medical device company's stock valued at $1,364,000 after acquiring an additional 22,320 shares during the period. 89.76% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Aviva Mcpherron sold 3,728 shares of Orthofix Medical stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total transaction of $39,181.28. Following the transaction, the insider owned 46,322 shares in the company, valued at approximately $486,844.22. The trade was a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.

Orthofix Medical Stock Performance

Shares of NASDAQ:OFIX traded up $0.06 during trading on Monday, reaching $14.61. The company had a trading volume of 83,876 shares, compared to its average volume of 335,259. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.50. The firm has a market capitalization of $576.75 million, a price-to-earnings ratio of -4.60 and a beta of 0.86. Orthofix Medical Inc. has a fifty-two week low of $10.24 and a fifty-two week high of $20.73. The stock's fifty day moving average price is $12.54 and its 200 day moving average price is $13.31.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last posted its earnings results on Tuesday, August 5th. The medical device company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.40). Orthofix Medical had a negative return on equity of 25.43% and a negative net margin of 15.29%.The firm had revenue of $203.12 million for the quarter, compared to analysts' expectations of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. As a group, equities research analysts predict that Orthofix Medical Inc. will post -2.81 EPS for the current year.

Wall Street Analyst Weigh In

OFIX has been the subject of several research reports. Barrington Research upgraded shares of Orthofix Medical to a "strong-buy" rating and set a $16.00 price target for the company in a research note on Monday, June 23rd. Wall Street Zen upgraded shares of Orthofix Medical from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, JMP Securities restated a "market perform" rating on shares of Orthofix Medical in a research note on Friday, June 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Orthofix Medical has a consensus rating of "Buy" and a consensus target price of $21.50.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.